Close
Help




JOURNAL

Biomarkers in Cancer

Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers

Submit a Paper


Biomarkers in Cancer 2016:Suppl. 1 1-14

Review

Published on 11 Feb 2016

DOI: 10.4137/BIC.S34417


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer

Abstract

Significant advances in our knowledge of cancer genomes are rapidly changing the way we think about tumor biology and the heterogeneity of cancer. Recent successes in genomically-guided treatment approaches accompanied by more sophisticated sequencing techniques have paved the way for deeper investigation into the landscape of genomic rearrangements in cancer. While considerable research on solid tumors has focused on point mutations that directly alter the coding sequence of key genes, far less is known about the role of somatic rearrangements. With many recurring alterations observed across tumor types, there is an obvious need for functional characterization of these genomic biomarkers in order to understand their relevance to tumor biology, therapy, and prognosis. As personalized therapy approaches are turning toward genomic alterations for answers, these biomarkers will become increasingly relevant to the practice of precision medicine. This review discusses the emerging role of genomic rearrangements in breast cancer, with a particular focus on fusion genes. In addition, it raises several key questions on the therapeutic value of such rearrangements and provides a framework to evaluate their significance as predictive and prognostic biomarkers.



Downloads

PDF  (1.99 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Biomarkers in Cancer
Biomarkers in Cancer, was again a pleasant experience.  We received helpful suggestions from the reviewers and an efficient, very professional editing processing process afterwards. Excellent team-work!  We hope for the same quantity of reads/citations as for our previous publication in Clinical Medicine Insights: Oncology.
Dr Cornelis F.M. Sier (Leiden University Medical Center, Netherlands)
More Testimonials

Quick Links


New article and journal news notification services